These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 32793226)

  • 1. Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.
    Richardson N; Ng STH; Wraith DC
    Front Immunol; 2020; 11():1586. PubMed ID: 32793226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease.
    Horst AK; Kumashie KG; Neumann K; Diehl L; Tiegs G
    Cell Mol Immunol; 2021 Jan; 18(1):92-111. PubMed ID: 33110250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mechanism of Action of Antigen Processing Independent T Cell Epitopes Designed for Immunotherapy of Autoimmune Diseases.
    Shepard ER; Wegner A; Hill EV; Burton BR; Aerts S; Schurgers E; Hoedemaekers B; Ng STH; Streeter HB; Jansson L; Wraith DC
    Front Immunol; 2021; 12():654201. PubMed ID: 33936079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications.
    Fucikova J; Palova-Jelinkova L; Bartunkova J; Spisek R
    Front Immunol; 2019; 10():2393. PubMed ID: 31736936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity as the trigger of systemic autoimmune diseases.
    Saferding V; Blüml S
    J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the liver to induce antigen-specific immune tolerance.
    Gottwick C; Carambia A; Herkel J
    Semin Immunopathol; 2022 Jul; 44(4):475-484. PubMed ID: 35513495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manipulating antigen presentation for antigen-specific immunotherapy of autoimmune diseases.
    Streeter HB; Wraith DC
    Curr Opin Immunol; 2021 Jun; 70():75-81. PubMed ID: 33878516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific immune decoys intercept and exhaust autoimmunity to prevent disease.
    Griffin JD; Song JY; Huang A; Sedlacek AR; Flannagan KL; Berkland CJ
    Biomaterials; 2019 Nov; 222():119440. PubMed ID: 31450159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Function of Antigen-Presenting Cells in Type 1 Diabetes: A Challenge for Antigen-Specific Immunotherapy?
    Creusot RJ; Postigo-Fernandez J; Teteloshvili N
    Diabetes; 2018 Aug; 67(8):1481-1494. PubMed ID: 30030289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune tolerance by dendritic cells: implications for preventative and therapeutic immunotherapy of autoimmune disease.
    Thompson AG; Thomas R
    Immunol Cell Biol; 2002 Dec; 80(6):509-19. PubMed ID: 12406384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity: basic mechanisms and implications in endocrine diseases. Part II.
    Ballotti S; Chiarelli F; de Martino M
    Horm Res; 2006; 66(3):142-52. PubMed ID: 16807509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity, tolerance and autoimmunity in the liver: A comprehensive review.
    Doherty DG
    J Autoimmun; 2016 Jan; 66():60-75. PubMed ID: 26358406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering antigen-presenting cells for immunotherapy of autoimmunity.
    Smith CT; Wang Z; Lewis JS
    Adv Drug Deliv Rev; 2024 Jul; 210():115329. PubMed ID: 38729265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons and innate immune activation in autoimmune congenital heart block.
    Ambrosi A; Thorlacius GE; Sonesson SE; Wahren-Herlenius M
    Scand J Immunol; 2021 Jan; 93(1):e12995. PubMed ID: 33188653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
    Gianchecchi E; Delfino DV; Fierabracci A
    Front Immunol; 2021; 12():616853. PubMed ID: 33679757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological therapies in patients with liver disease: are they really lifesavers?
    Vitale G; Gitto S; Campani C; Turco L; Baldan A; Marra F; Morelli MC
    Expert Opin Biol Ther; 2022 Apr; 22(4):473-490. PubMed ID: 34860629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis.
    Fasano R; Malerba E; Prete M; Solimando AG; Buonavoglia A; Silvestris N; Leone P; Racanelli V
    Front Immunol; 2021; 12():814155. PubMed ID: 35116039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity].
    Müller C
    Schweiz Med Wochenschr; 1997 Mar; 127(9):333-40. PubMed ID: 9132931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.